PROVAYBLUE 5 mg/mL

PROVAYBLUE 5 mg/mL is an intravenous injection containing methylene blue, a medication used for various therapeutic purposes. This single-dose vial is manufactured by American Regent, Inc. in the USA.

Methylene blue, the active ingredient in PROVAYBLUE, is commonly used for its antimalarial properties and as a diagnostic aid in certain medical procedures. It may also be utilized for its potential benefits in managing methemoglobinemia, a condition where the blood cannot carry oxygen effectively. Additionally, methylene blue has been explored for its use in treating certain types of depression and for its antioxidant properties.

When administered intravenously, methylene blue can cause a temporary blue discoloration of the skin and urine. Some individuals may experience side effects such as nausea, vomiting, or dizziness. It is important to follow medical advice and monitor for any adverse reactions.

PROVAYBLUE should be handled with care, ensuring proper sterile techniques during administration. It is crucial to inform healthcare providers about any allergies or medical conditions before use. The medication should be stored as per the manufacturer's guidelines to maintain its efficacy.

Methylene blue may interact with certain medications, particularly those that affect serotonin levels or are metabolized by the liver. It is advisable to consult a healthcare professional before combining methylene blue with other treatments. Alcohol consumption should be avoided as it may exacerbate side effects.